Asthma + Lung UK becomes an affiliate of Our Future Health
1 in every 5 people will have a lung condition in their lifetime and 5.4 million people in the UK live with asthma. Lung disease is now the third most common cause of death, costing the NHS more than £9 billion every year. Asthma + Lung UK have a vision for a world where everyone has healthy lungs and where lung health is prioritised through better understanding, research, treatment and support.
Our Future Health is joining with many of the UK’s leading health research charities who are providing valuable support and expertise to help develop Our Future Health. They will make a big impact in allowing us to ultimately change the way we prevent, detect and treat diseases.
Andrew Roddam, CEO of Our Future Health, said: “We look forward to working alongside Asthma + Lung UK as an affiliate charity of Our Future Health. With their support we hope to ensure our programme helps many more people who are affected by lung conditions.”
Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, said: “We’re delighted to be working with Our Future Health, the UK’s largest health research programme. Lung conditions such as asthma, chronic obstructive pulmonary disease (COPD), fibrosis and chronic infections affect hundreds of thousands of people yet are still poorly understood. We don’t know why some people develop lung diseases and others don’t, and we haven’t identified all the early signs of lung disease, which would help us diagnose and treat them sooner. This coupled with a lack of comprehensive data undermines researchers’ efforts to understand the long-term development of lung disease and limits opportunities to develop new treatments.
“We want to change this. By working with Our Future Health, we hope to address these challenges and identify new ways to improve health outcomes for those affected by lung conditions. In the next decade we also hope a fifth of all deaths from lung disease will be prevented.”
Read more about our partnerships.